AVBP
ArriVent BioPharma, Inc.
28.50$
-5.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.8% | 99.9% | 98.1% | 82.6% | 99.9% | |
| 86.6% | 89.4% | 92.2% | 27.0% | 13.7% | |
| 86.6% | 89.4% | 92.2% | 79.6% | 93.9% | |
| 0.6% | 0.3% | 0.5% | 0.2% | 0.0% | |
| – | – | -0.1% | – | – | |
| 4.2% | 4.6% | 7.2% | 6.3% | 7.8% | |
| 4.2% | 4.6% | 7.1% | 6.3% | 7.8% | |
| – | 0.1% | 0.1% | 0.1% | 0.0% | |
| 0.7% | 1.7% | 2.8% | 1.4% | 1.8% | |
| 95.8% | 95.4% | 92.8% | 93.7% | 92.2% | |
| -119.9% | -48.4% | -96.8% | -86.7% | -121.5% | |
| 3.0% | 18.3% | 19.6% | 11.4% | 11.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.